Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation - Poll - MDSpire

Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation

  • By

  • Marco Salvini

  • Fabrizio Maggi

  • Camilla Damonte

  • Lorenzo Mortara

  • Antonino Bruno

  • Barbara Mora

  • Marco Brociner

  • Roberta Mattarucchi

  • Alessia Ingrassia

  • Davide Sirocchi

  • Benedetta Bianchi

  • Stefania Agnoli

  • Matteo Gallazzi

  • Michele Merli

  • Andrea Ferrario

  • Raffaella Bombelli

  • Daniela Barraco

  • Andreina Baj

  • Lorenza Bertù

  • Paolo A. Grossi

  • Francesco Passamonti

  • October 11, 2021

  • 0 min

Share

Original Source(s)

Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation

  • by Marco Salvini, Fabrizio Maggi, Camilla Damonte, Lorenzo Mortara, Antonino Bruno, Barbara Mora, Marco Brociner, Roberta Mattarucchi, Alessia Ingrassia, Davide Sirocchi, Benedetta Bianchi, Stefania Agnoli, Matteo Gallazzi, Michele Merli, Andrea Ferrario, Raffaella Bombelli, Daniela Barraco, Andreina Baj, Lorenza Bertù, Paolo A. Grossi, Francesco Passamonti

  • October 11, 2021

Related Content

Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient’s bedside